• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于磁共振成像和超声心动图对肥厚型心肌病患者二尖瓣反流严重程度的评估比较。

Comparison of mitral regurgitation severity assessments based on magnetic resonance imaging and echocardiography in patients with hypertrophic cardiomyopathy.

机构信息

Magnetic Resonance Unit, National Institute of Cardiology, ul. Alpejska 42, 04-628, Warsaw, Poland.

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland.

出版信息

Sci Rep. 2021 Oct 6;11(1):19902. doi: 10.1038/s41598-021-99446-y.

DOI:10.1038/s41598-021-99446-y
PMID:34615936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8494871/
Abstract

Mitral regurgitation (MR), which is one of the factors responsible for heart failure symptoms and the development of atrial fibrillation, is an important feature of hypertrophic cardiomyopathy (HCM), and its presence affects which treatment options are chosen. Although cardiac magnetic resonance imaging (MRI) is considered the reference standard for assessing the regurgitant volume (RV) and fraction (RF), echocardiography is the most common method for assessing MR severity. Accordingly, the aim of this study was to compare the results of echocardiography and cardiac MRI for assessing MR severity in a cohort of patients with HCM. MR severity was assessed in 53 patients using cardiac MRI by determining the mitral RV (MRV) and mitral RF (MRF). The results were graded according to thresholds recommended in current guidelines. MR severity assessed by echocardiography was graded by integrating indices of severity. Greater than mild MR, as assessed using echocardiography, was present in 22 patients (41.5%) with HCM and in none of the control patients (p = 0.001). In all, 31 patients (58.5%) had no more than mild MR. When MR severity was assessed using different methods, either moderate (kappa = 0.44, 95% confidence interval = 0.21-0.67), poor or no agreement was found between MRI-derived and echocardiography-derived grades. HCM patients with echocardiography-derived moderate and severe MR had similar median MRVs and MRFs (p = 0.59 and p = 0.11, respectively). In HCM patients, cardiac MRI and echocardiography were at most in modest agreement in assessing MR severity. Importantly, echocardiography-derived moderate and severe MR were not distinguishable by either MRV or MRF.

摘要

二尖瓣反流(MR)是心力衰竭症状和心房颤动发展的原因之一,也是肥厚型心肌病(HCM)的一个重要特征,其存在影响了治疗选择。尽管心脏磁共振成像(MRI)被认为是评估反流量(RV)和分数(RF)的参考标准,但超声心动图是评估 MR 严重程度最常用的方法。因此,本研究旨在比较超声心动图和心脏 MRI 评估 HCM 患者 MR 严重程度的结果。通过确定二尖瓣 RV(MRV)和二尖瓣 RF(MRF),对 53 例 HCM 患者进行心脏 MRI 评估 MR 严重程度。根据现行指南推荐的标准来分级。通过整合严重程度指数来评估超声心动图评估的 MR 严重程度。使用超声心动图评估,22 例(41.5%)HCM 患者存在中度以上 MR,而对照组患者无一例存在(p = 0.001)。共有 31 例(58.5%)患者的 MR 程度不超过轻度。当使用不同方法评估 MR 严重程度时,MRI 与超声心动图分级之间的一致性较差或无一致性(kappa 值为 0.44,95%置信区间为 0.21-0.67)。在超声心动图评估为中度和重度 MR 的 HCM 患者中,MRV 和 MRF 的中位数相似(p = 0.59 和 p = 0.11)。在 HCM 患者中,心脏 MRI 和超声心动图在评估 MR 严重程度方面最多只有中等程度的一致性。重要的是,无论是通过 MRV 还是 MRF,超声心动图评估的中度和重度 MR 都无法区分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70b2/8494871/bdb089ec6112/41598_2021_99446_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70b2/8494871/65a1f73f5ede/41598_2021_99446_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70b2/8494871/da2572c926d1/41598_2021_99446_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70b2/8494871/bdb089ec6112/41598_2021_99446_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70b2/8494871/65a1f73f5ede/41598_2021_99446_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70b2/8494871/da2572c926d1/41598_2021_99446_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70b2/8494871/bdb089ec6112/41598_2021_99446_Fig3_HTML.jpg

相似文献

1
Comparison of mitral regurgitation severity assessments based on magnetic resonance imaging and echocardiography in patients with hypertrophic cardiomyopathy.基于磁共振成像和超声心动图对肥厚型心肌病患者二尖瓣反流严重程度的评估比较。
Sci Rep. 2021 Oct 6;11(1):19902. doi: 10.1038/s41598-021-99446-y.
2
Evaluation and implications of mitral regurgitation using cMRI in patients with hypertrophic cardiomyopathy.应用心脏磁共振成像评估肥厚型心肌病患者的二尖瓣反流及其意义。
Eur Rev Med Pharmacol Sci. 2023 May;27(9):4006-4018. doi: 10.26355/eurrev_202305_32306.
3
Accuracy of Jet Direction on Doppler Echocardiography in Identifying the Etiology of Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy.超声心动图测量射流方向对梗阻性肥厚型心肌病二尖瓣反流病因的诊断价值。
J Am Soc Echocardiogr. 2019 Mar;32(3):333-340. doi: 10.1016/j.echo.2018.10.011. Epub 2018 Dec 28.
4
Direct mitral regurgitation quantification in hypertrophic cardiomyopathy using 4D flow CMR jet tracking: evaluation in comparison to conventional CMR.应用 4D 流磁共振喷射轨迹法直接定量分析肥厚型心肌病的二尖瓣反流:与传统磁共振比较的评估。
J Cardiovasc Magn Reson. 2021 Dec 6;23(1):138. doi: 10.1186/s12968-021-00828-y.
5
Quantitative Evaluation of Mitral Regurgitation Secondary to Mitral Valve Prolapse by Magnetic Resonance Imaging and Echocardiography.磁共振成像和超声心动图对二尖瓣脱垂继发二尖瓣反流的定量评估
Am J Cardiol. 2015 Nov 1;116(9):1405-10. doi: 10.1016/j.amjcard.2015.07.064. Epub 2015 Aug 14.
6
Prognostic Implications of Magnetic Resonance-Derived Quantification in Asymptomatic Patients With Organic Mitral Regurgitation: Comparison With Doppler Echocardiography-Derived Integrative Approach.磁共振衍生定量分析在无症状性器质性二尖瓣反流患者中的预后意义:与多普勒超声心动图衍生综合方法的比较。
Circulation. 2018 Mar 27;137(13):1349-1360. doi: 10.1161/CIRCULATIONAHA.117.029332. Epub 2017 Dec 21.
7
Isolated mitral regurgitation: quantitative assessment with 64-section multidetector CT--comparison with MR imaging and echocardiography.孤立性二尖瓣反流:64层多排螺旋CT定量评估——与磁共振成像及超声心动图的比较
Radiology. 2009 Aug;252(2):369-76. doi: 10.1148/radiol.2522081714. Epub 2009 May 18.
8
Prognostic Value of Mitral Regurgitation in Patients with Primary Hypertrophic Cardiomyopathy.原发性肥厚型心肌病患者二尖瓣反流的预后价值。
Medicina (Kaunas). 2023 Oct 9;59(10):1798. doi: 10.3390/medicina59101798.
9
Characterization of Primary Mitral Regurgitation With Flail Leaflet and/or Wall-Impinging Flow.二尖瓣脱垂伴或不伴瓣叶对合缘撞击的原发性二尖瓣关闭不全的特征。
J Am Coll Cardiol. 2021 Dec 21;78(25):2537-2546. doi: 10.1016/j.jacc.2021.09.1382.
10
Impact of exercise-induced mitral regurgitation on hypertrophic cardiomyopathy outcomes.运动诱发的二尖瓣反流对肥厚型心肌病结局的影响。
Eur Heart J Cardiovasc Imaging. 2016 Oct;17(10):1110-7. doi: 10.1093/ehjci/jev242. Epub 2015 Oct 16.

引用本文的文献

1
Prospective Quantification of Tricuspid Regurgitation With Echocardiography vs 4D Flow Cardiac Magnetic Resonance.超声心动图与4D流心脏磁共振对三尖瓣反流的前瞻性定量分析
JACC Adv. 2025 Jun;4(6 Pt 1):101759. doi: 10.1016/j.jacadv.2025.101759. Epub 2025 May 2.
2
Comparison of Nonclassic and Classic Phenotype of Hypertrophic Cardiomyopathy Focused on Prognostic Cardiac Magnetic Resonance Parameters: A Single-Center Observational Study.聚焦于预后性心脏磁共振参数的肥厚型心肌病非典型与典型表型比较:一项单中心观察性研究
Diagnostics (Basel). 2022 Apr 28;12(5):1104. doi: 10.3390/diagnostics12051104.

本文引用的文献

1
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 ACC/AHA 瓣膜性心脏病患者管理指南:执行摘要:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932. Epub 2020 Dec 17.
2
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 年美国心脏病学会/美国心脏协会肥厚型心肌病诊断和治疗指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20.
3
Impact of cardiac magnetic resonance on the diagnosis of hypertrophic cardiomyopathy - a 10-year experience with over 1000 patients.心脏磁共振成像对肥厚型心肌病诊断的影响——10 年 1000 多例患者的经验。
Eur Radiol. 2021 Mar;31(3):1194-1205. doi: 10.1007/s00330-020-07207-8. Epub 2020 Sep 2.
4
Left ventricular global function index by magnetic resonance imaging - a novel marker for differentiating cardiac amyloidosis from hypertrophic cardiomyopathy.磁共振成像左心室整体功能指数——一种鉴别心脏淀粉样变性与肥厚型心肌病的新型标志物。
Sci Rep. 2020 Mar 13;10(1):4707. doi: 10.1038/s41598-020-61608-9.
5
Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study.韩国肥厚型心肌病患病率和发病率的趋势:一项全国基于人群的队列研究。
PLoS One. 2020 Jan 13;15(1):e0227012. doi: 10.1371/journal.pone.0227012. eCollection 2020.
6
The Significance of Interstitial Fibrosis on Left Ventricular Function in Hypertensive versus Hypertrophic Cardiomyopathy.间质纤维化在高血压与肥厚型心肌病左心室功能中的意义。
Sci Rep. 2018 Jul 3;8(1):9995. doi: 10.1038/s41598-018-27049-1.
7
Prognostic Implications of Magnetic Resonance-Derived Quantification in Asymptomatic Patients With Organic Mitral Regurgitation: Comparison With Doppler Echocardiography-Derived Integrative Approach.磁共振衍生定量分析在无症状性器质性二尖瓣反流患者中的预后意义:与多普勒超声心动图衍生综合方法的比较。
Circulation. 2018 Mar 27;137(13):1349-1360. doi: 10.1161/CIRCULATIONAHA.117.029332. Epub 2017 Dec 21.
8
Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.应用主动脉和肺血流数据对肥厚型心肌病患者二尖瓣反流进行定量评估:左心室流出道梗阻和不同左心室分段方法的影响。
J Cardiovasc Magn Reson. 2017 Dec 21;19(1):105. doi: 10.1186/s12968-017-0417-8.
9
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.
10
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance.原发性瓣膜反流的非侵入性评估建议:美国超声心动图学会与心血管磁共振学会合作制定的报告
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371. doi: 10.1016/j.echo.2017.01.007. Epub 2017 Mar 14.